Indivior Pharmaceuticals Inc
(INDV)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 319,000 | 316,000 | 774,000 | 1,102,000 | 858,000 |
| Marketable Securities | 1,000 | 94,000 | 119,000 | N/A | N/A |
| Receivables | 288,000 | 254,000 | 225,000 | 215,000 | 186,000 |
| Inventories | 178,000 | 135,000 | 114,000 | 95,000 | 93,000 |
| Other current assets | 53,000 | 467,000 | 27,000 | 32,000 | 50,000 |
| TOTAL | $839,000 | $1,266,000 | $1,259,000 | $1,444,000 | $1,187,000 |
| Non-Current Assets | |||||
| PPE Net | 100,000 | 84,000 | 54,000 | 58,000 | 60,000 |
| Investments And Advances | 27,000 | 41,000 | 98,000 | 0 | 0 |
| Intangibles | 6,000 | 13,000 | 70,000 | 82,000 | 62,000 |
| Other Non-Current Assets | 348,000 | 356,000 | 288,000 | 248,000 | 222,000 |
| TOTAL | $481,000 | $494,000 | $510,000 | $388,000 | $344,000 |
| Total Assets | $1,319,000 | $1,760,000 | $1,769,000 | $1,832,000 | $1,531,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 18,000 | 3,000 | 3,000 | 3,000 | 4,000 |
| Accounts payable and accrued liabilities | 232,000 | 204,000 | 617,000 | 720,000 | 524,000 |
| Accrued Expenses | 661,000 | 1,027,000 | N/A | N/A | N/A |
| Other current liabilities | 11,000 | 40,000 | 382,000 | 66,000 | 48,000 |
| TOTAL | $939,000 | $1,290,000 | $1,019,000 | $804,000 | $599,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 315,000 | 237,000 | 237,000 | 239,000 | 230,000 |
| Other Non-Current Liabilities | 415,000 | 424,000 | 462,000 | 586,000 | 620,000 |
| TOTAL | $730,000 | $661,000 | $699,000 | $825,000 | $850,000 |
| Total Liabilities | $1,668,000 | $1,951,000 | $1,718,000 | $1,629,000 | $1,449,000 |
| Shareholders' Equity | |||||
| Common Shares | 62,000 | 68,000 | 68,000 | 70,000 | 73,000 |
| Retained earnings | -454,000 | -295,000 | 1,303,000 | 1,438,000 | 1,311,000 |
| Other shareholders' equity | -46,000 | -52,000 | -1,328,000 | -1,312,000 | -1,308,000 |
| TOTAL | $-348,000 | $-191,000 | $51,000 | $203,000 | $82,000 |
| Total Liabilities And Equity | $1,320,000 | $1,760,000 | $1,769,000 | $1,832,000 | $1,531,000 |